&nbsp;

EmotionalandPsychologicalWell-beingforGyngecologicalCancerSurvivors.pdf

Jul 2024

Document

Emotional-and-Psychological-Well-being-Gynecological_FR.pdf

Jul 2024

Regimen

ELRA; ELRA(RAMP)

Cancer Type:

Hematologic,

Multiple Myeloma

, Collapse Show fewer tags

Intent: Palliative

Drugs Used:

elranatamab (Compassionate)

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

ENFO

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Funding:

New Drug Funding Program

Enfortumab Vedotin - Previously Treated Advanced or Metastatic Urothelial Cancer

, Collapse Show fewer tags

Drugs Used:

enfortumab vedotin

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2025

Guidelines and Advice

Endometrial Cancer Molecular Testing Recommendations Report

Status: Current
Version: 1

Nov 2024

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Status: Current
ID: PET 2024-1

Mar 2025

Document

EndometrioidOvarianCancerTreatmentPathwayMap.pdf

New

Apr 2025

Document

E.1.50-CAR-TReferralWorksheet.pdf

New

May 2025

Guidelines and Advice

Effective Teaching Strategies and Methods for Cancer Patient Education

Status: Current
ID: GL 20-2
Version: 2

Updated

Apr 2025

Guidelines and Advice

Effective Use of Advanced Practice Nurses in the Delivery of Adult Cancer Services in Ontario

Status: In-Review
ID: 16-4

May 2015

Regimen

ENHE

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab Deruxtecan - Unresectable Locally Advanced or Metastatic Breast Cancer

New Drug Funding Program

Trastuzumab Deruxtecan - HER2-low Unresectable Locally Advanced or Metastatic Breast Cancer